AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2023
Nov 8, 2023
31949_dirs_2023-11-08_0edf492c-64b2-4c47-be4f-3c1c3f6ce7a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-11-07
Reporting Person: Shah Pritesh (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-07 | Ordinary Shares | S | 382.00 | $12.65 | Disposed | 124511.00 | Direct |
Footnotes
F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3